Harrow HROW Net debt / EBITDA

Net debt / EBITDA at other companies

AbbVieABBV

2.5×—

Eton Pharmaceuticals, Inc.ETON

7.6×—

Bausch + LombBLCO

6.4×-3.7×

Opko HealthOPK

1.2×—

Bausch Health CompaniesBHC

10.9×+3.6×

Regeneron PharmaceuticalsREGN

0.1×-0.1×

FAQ

What is Harrow's net debt / EBITDA?

Harrow (HROW) reported net debt / EBITDA of 9.9× in Q1 2026.

How has Harrow's net debt / EBITDA changed year-over-year?

Harrow's net debt / EBITDA decreased by 83.9% year-over-year, from 61.4× to 9.9×.

What is the long-term trend for Harrow's net debt / EBITDA?

Over 4 years (2020 to 2025), Harrow's net debt / EBITDA has grown at a -13.3% compound annual growth rate (CAGR), from 10.1× to 5.7×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.